Your browser doesn't support javascript.
loading
Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20+ B-cell non-Hodgkin lymphomas: a systematic review and meta-analysis.
Luo, Chengxin; Wu, Guixian; Huang, Xiangtao; Ma, Yanni; Zhang, Yali; Song, Qiuyue; Xie, Mingling; Sun, Yanni; Huang, Yarui; Huang, Zhen; Hou, Yu; Xu, Shuangnian; Chen, Jieping; Li, Xi.
Affiliation
  • Luo C; Center for Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Wu G; Key Laboratory of Cancer Immunotherapy of Chongqing, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Huang X; Center for Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Ma Y; Key Laboratory of Cancer Immunotherapy of Chongqing, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Zhang Y; Center for Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Song Q; Key Laboratory of Cancer Immunotherapy of Chongqing, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Xie M; Center for Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Sun Y; Key Laboratory of Cancer Immunotherapy of Chongqing, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Huang Y; Center for Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Huang Z; Key Laboratory of Cancer Immunotherapy of Chongqing, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Hou Y; Department of Health Statistics, Third Military Medical University, Chongqing, China.
  • Xu S; Center for Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Chen J; Key Laboratory of Cancer Immunotherapy of Chongqing, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Li X; Center for Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China.
Sci Rep ; 11(1): 3255, 2021 02 05.
Article in En | MEDLINE | ID: mdl-33547368
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Antigens, CD20 / Rituximab / Antineoplastic Agents, Immunological Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Sci Rep Year: 2021 Document type: Article Affiliation country: China Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Antigens, CD20 / Rituximab / Antineoplastic Agents, Immunological Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Sci Rep Year: 2021 Document type: Article Affiliation country: China Country of publication: United kingdom